GlucoTrack (GCTK) Fundamental Analysis: Revenue, Earnings & Valuation

0.47 / 10

Underperform

Fundamental analysis yields a poor 0.47 score. Asset‑MV and Profit‑MV show modest strength, but cash metrics, ROE, ROA and profitability ratios are deeply negative, placing the stock in the lowest performance groups. Overall fundamentals are guarded.

Analysis Checks(3/10)

ROA (%)

Value-221.63

Score0/3

Weight21.81%

1M Return-6.12%

Annualized return on equity (%)

Value-47.90

Score0/3

Weight20.85%

1M Return-5.73%

Profit-MV

Value0.41

Score2/3

Weight-19.94%

1M Return3.26%

Cash-UP

Value-0.01

Score2/3

Weight18.19%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-295.50

Score0/3

Weight21.81%

1M Return-6.12%

ROE (diluted) (%)

Value-572.88

Score0/3

Weight21.90%

1M Return-5.82%

Asset-MV

Value-0.48

Score3/3

Weight-32.18%

1M Return4.79%

ROE (%)

Value-35.92

Score0/3

Weight20.85%

1M Return-5.73%

Cash-MV

Value-0.09

Score1/3

Weight15.68%

1M Return-3.56%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight11.04%

1M Return-2.37%

Is GCTK undervalued or overvalued?

GCTK scores 0.47/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 0.00% net margin, -0.04 P/E ratio, 0.38 P/B ratio, and -380.78% earnings growth, these metrics solidify its Underperform investment rating.